Bioquell Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Months 29 Days
About Bioquell Pharma
Bioquell Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2024 ( five months 29 days old ). Its registered office is in Thane, Maharashtra, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Rangnath, Dhananjay Singh, Ratnesh Pandey, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497MH2024PTC431187
- Company No.
431187
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Who are the key members and board of directors at Bioquell Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Rangnath  | Director | 27-Aug-2024 | Current |
| Dhananjay Singh | Director | 27-Aug-2024 | Current |
| Ratnesh Pandey | Director | 27-Aug-2024 | Current |
| Dinesh Yadav | Director | 27-Aug-2024 | Current |
| Lokesh Patil | Director | 27-Aug-2024 | Current |
Financial Performance of Bioquell Pharma.
Enhance accessibility to Bioquell Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bioquell Pharma?
Unlock access to Bioquell Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Instaray Pharmaceuticals LlpSudhir Rangnath and Dhananjay Singh are mutual person
- Do5ine Techno India Private Limited
Sudhir Rangnath and Dhananjay Singh are mutual person
- Instaray Healthcare Private Limited
Sudhir Rangnath, Dhananjay Singh and 2 more are mutual person
- Instaray Lifescience Private Limited
Sudhir Rangnath and Dhananjay Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioquell Pharma?
Unlock and access historical data on people associated with Bioquell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioquell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioquell Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.